Pelvic Adhesiolysis in India
Get Pelvic Adhesiolysis at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Pelvic Adhesiolysis in UAE
Pelvic Adhesiolysis at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Pelvic adhesiolysis is a surgical procedure to excise or lyse intra-abdominal and pelvic adhesions — dense fibrous scar bands that tether organs such as the uterus, ovaries, fallopian tubes, bowel, and bladder — restoring normal anatomy, relieving chronic pelvic pain, and improving fertility outcomes. Reported success rates for symptom relief and anatomical restoration range from 70–85% when performed laparoscopically by high-volume gynecological surgeons using advanced energy devices and anti-adhesion adjuncts. GAF Healthcare connects international patients with JCI- and NABH-accredited hospitals in India and JCI- and DHA-licensed centres in Dubai and Abu Dhabi, offering expert surgical teams, transparent pricing, and end-to-end coordination at a fraction of Western costs.
Hospital Stay: 1–3 days (laparoscopic); 3–5 days (open/complex cases) • Total Stay in Country (Fit-to-Fly): 1–2 weeks for laparoscopic procedures; 3–4 weeks for open or extensive adhesiolysis • Success Rate: 70–85% (symptom relief and anatomical restoration)
What Is It?
Pelvic adhesions are abnormal fibrous bands of connective tissue that form between pelvic and abdominal organs as a consequence of prior surgery (most commonly hysterectomy, myomectomy, appendectomy, or caesarean section), pelvic inflammatory disease (PID) caused by Chlamydia trachomatis or Neisseria gonorrhoeae, endometriosis, or prior episodes of peritonitis. These bands mechanically distort tubo-ovarian anatomy, restrict visceral mobility, compress nerve plexuses, and create ischaemic traction zones, producing the clinical triad of chronic pelvic pain, dyspareunia, and secondary infertility. In severe cases, bowel adhesions cause partial or complete small-bowel obstruction, a potentially life-threatening complication requiring urgent surgical intervention.
The physiological impact of pelvic adhesions extends beyond mechanical distortion. Adhesion tissue is metabolically active, containing myofibroblasts, mast cells, and pro-inflammatory cytokines (IL-1β, TGF-β, TNF-α) that perpetuate a local inflammatory milieu, sensitise peritoneal nociceptors, and contribute to central pain sensitisation. Fallopian tube occlusion or distortion secondary to peritubal adhesions is implicated in up to 35% of female factor infertility diagnoses globally, making adhesiolysis a critical step in fertility-restoration surgery.
The current standard of care for pelvic adhesiolysis is minimally invasive laparoscopic surgery, which offers magnified visualisation of the operative field, reduced post-operative pain, shorter hospital stay, faster return to activity, and — critically — a lower rate of de novo adhesion formation compared with open laparotomy. Robotic-assisted laparoscopic adhesiolysis (using the da Vinci Xi or Si platform) is increasingly employed for dense, complex adhesions involving bowel or ureter, where wristed instrumentation and tremor filtration allow precise sharp dissection in confined spaces. Intra-operative use of anti-adhesion barriers such as Seprafilm (sodium hyaluronate/carboxymethylcellulose) or Adept (icodextrin 4% solution) is standard practice in high-volume centres to reduce recurrence.
Candidates
• ELIGIBLE PATIENTS:
• Women with chronic pelvic pain (≥6 months duration) unresponsive to analgesics (NSAIDs, low-dose tricyclics) and hormonal therapy, with adhesions confirmed on imaging or diagnostic laparoscopy
• Patients with secondary infertility or failed intrauterine insemination (IUI) cycles where hysterosalpingography (HSG) or sonohysterography (SHG) suggests tubo-ovarian adhesive disease
• Women with a history of ≥1 prior pelvic or abdominal surgery (caesarean section, appendectomy, myomectomy, ovarian cystectomy) presenting with new or progressive pelvic symptoms
• Patients with confirmed endometriosis (ASRM Stage III–IV) in whom adhesiolysis is performed concurrently with endometrioma excision or ablation
• Cases of recurrent partial small-bowel obstruction attributed to adhesive disease (in coordination with a colorectal or general surgeon)
• Patients with a Peritoneal Adhesion Index (PAI) score ≥4 on diagnostic laparoscopy, indicating clinically significant adhesive burden
• REQUIRED PRE-OPERATIVE DIAGNOSTICS:
• Transvaginal ultrasound (TVUS) with sliding organ sign assessment
• Hysterosalpingography (HSG) or hysterosalpingo-contrast sonography (HyCoSy) for tubal patency
• Diagnostic laparoscopy with adhesion mapping and PAI scoring (gold standard)
• MRI pelvis (1.5T or 3T with fat-suppression sequences) for deep infiltrating endometriosis or complex adhesive disease
• Full blood count (FBC), coagulation profile (PT/APTT/INR), renal and hepatic function tests
• Cervical swabs and STI screen (Chlamydia, Gonorrhoea) to exclude active infection
• Anaesthesia fitness assessment including ECG and chest X-ray for patients over 40 or with comorbidities
• CONTRAINDICATIONS:
• Active pelvic or abdominal infection (defer until infection fully treated)
• Severe uncorrected coagulopathy
• Uncontrolled medical comorbidities (uncompensated cardiac failure, severe pulmonary disease) precluding general anaesthesia
• Frozen pelvis with extensive bowel involvement requiring a bowel resection team unavailable at the planned centre
• Patient's refusal of blood products where intra-operative haemorrhage risk is high
Procedure
LAPAROSCOPIC ADHESIOLYSIS (STANDARD MINIMALLY INVASIVE APPROACH)
Laparoscopic adhesiolysis is performed under general anaesthesia through 3–4 small (5–12 mm) port incisions. The abdomen is insufflated with CO₂ to 12–15 mmHg. The surgeon uses a 0° or 30° high-definition (HD) or 4K laparoscope to identify adhesion type — filmy (avascular, easy to lyse with scissors or harmonic energy), vascular (requiring careful bipolar haemostasis), or dense fibrous (requiring sharp cold-scissors dissection close to the less vital structure). Adhesions are classified intra-operatively using the American Fertility Society (AFS) or Peritoneal Adhesion Index (PAI) scoring system to guide the extent of lysis. Key steps include: identification and protection of ureter, bowel serosa, and bladder wall prior to any energy use; sequential lysis from the most accessible planes inward; copious irrigation with warm Ringer's lactate to reduce fibrin deposition; and placement of anti-adhesion barriers (Seprafilm, Interceed, or icodextrin 4% solution/Adept) on raw peritoneal surfaces before port closure.
ROBOTIC-ASSISTED ADHESIOLYSIS (ADVANCED APPROACH — da Vinci Xi/Si Platform)
Robotic-assisted adhesiolysis is the preferred approach for complex or recurrent adhesive disease, particularly when bowel, ureter, or bladder is densely adherent to adnexal structures. The da Vinci system provides 10× magnification with a true 3D HD operative field, 7-degree-of-freedom wristed instrumentation (EndoWrist), motion scaling, and tremor filtration — enabling precise sharp dissection in anatomically confined pelvic spaces where conventional laparoscopy is limited by instrument triangulation. Robotic adhesiolysis significantly reduces the risk of inadvertent enterotomy or ureteral injury in redo-pelvic surgery. Operative time is marginally longer but post-operative recovery profiles are equivalent to or better than standard laparoscopy.
OPEN LAPAROTOMY ADHESIOLYSIS (RESERVED FOR COMPLEX/EMERGENCY CASES)
Open adhesiolysis via Pfannenstiel or midline laparotomy incision is reserved for: (a) bowel obstruction requiring resection and anastomosis, (b) failed laparoscopic entry due to dense anterior abdominal wall adhesions (confirmed by pre-operative CT abdomen), or (c) concurrent major pelvic reconstructive procedures. Open surgery carries a higher risk of de novo adhesion formation post-operatively; therefore, intra-peritoneal Seprafilm placement is strongly recommended at wound closure.
ADJUNCT & COMBINATION PROCEDURES
• Concurrent laparoscopic excision (excisional > ablative) of endometriosis implants (CO₂ laser, harmonic scalpel, or monopolar needle) where adhesions co-exist with endometriosis
• Salpingolysis and fimbrioplasty for peritubal adhesions causing tubal factor infertility
• Ovarian drilling in PCOS patients undergoing adhesiolysis for concomitant peri-ovarian adhesions
• Laparoscopic uterosacral nerve ablation (LUNA) or presacral neurectomy (PSN) for refractory central pelvic pain — performed concurrently at specialised centres
• Post-operative hormonal suppression with GnRH agonists (e.g., leuprolide acetate 3.75 mg/month) for 3–6 months in endometriosis-related adhesions to suppress recurrence
Cost of Pelvic Adhesiolysis: India vs. UAE
The cost of pelvic adhesiolysis varies significantly depending on surgical complexity (laparoscopic vs. robotic vs. open), operative duration, hospital tier, and the extent of concurrent procedures (e.g., endometriosis excision, salpingolysis). Both India and the UAE offer internationally accredited care at costs substantially below those in the United States (where equivalent procedures cost USD 15,000–40,000) or the United Kingdom. India typically offers the lowest price point globally — 40–60% less than equivalent UAE pricing — while the UAE provides premium hospital environments, cutting-edge infrastructure, and proximity for patients from Europe, Africa, and the Middle East.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $1,500 – $4,500 | ~52% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $3,500 – $9,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PHASE 1 — PRE-OPERATIVE PREPARATION (4–6 WEEKS BEFORE TRAVEL)
• GAF Healthcare coordinates remote consultation with the chosen gynecological surgeon via secure video link; patient submits medical records, prior operative notes, imaging, and HSG/HyCoSy reports
• Surgeon reviews PAI scoring potential and recommends laparoscopic vs. robotic vs. open approach
• Pre-operative blood panel, coagulation screen, and pelvic MRI arranged locally or upon arrival
• Bowel preparation protocol issued (low-residue diet 48 hours pre-op; bowel prep agent if bowel adhesions suspected)
• Cessation of anticoagulants, NSAIDs, and hormonal medications per anaesthetist's guidance
• Travel medical visa documentation prepared by GAF Healthcare case manager
PHASE 2 — ARRIVAL & IMMEDIATE PRE-OP (DAYS 1–2 IN DESTINATION)
• Airport pickup and transfer to accredited hospital or GAF-partnered accommodation
• In-person surgical consultation and informed consent; anaesthesia pre-assessment including ECG and chest X-ray
• Admission day before surgery; nil-by-mouth from midnight; pre-operative antibiotic prophylaxis (Cefazolin 2g IV) and VTE prophylaxis (LMWH + TED stockings) commenced
PHASE 3 — SURGICAL PROCEDURE (DAY 2 OR 3)
• General anaesthesia (TIVA or inhalational); procedure duration 60–180 minutes depending on adhesion complexity
• Laparoscopic/robotic port placement; CO₂ insufflation; systematic adhesion mapping and lysis using cold scissors, harmonic scalpel (Ethicon Harmonic Ace+7), or bipolar forceps
• Anti-adhesion barrier placement (Seprafilm or Adept irrigation) before port closure
• Patient wakes in recovery room; urine output monitored via indwelling catheter (removed at 12–24 hours post-op)
PHASE 4 — IMMEDIATE POST-OPERATIVE PERIOD (DAYS 3–5 IN HOSPITAL)
• Multimodal analgesia: paracetamol 1g QDS + diclofenac 75mg BD (or etoricoxib 90mg OD) + low-dose tramadol PRN; opioids avoided where possible to reduce ileus risk
• Early mobilisation: sitting out of bed at 6 hours, ambulation at 12–24 hours post-op
• Light diet resumed at 24 hours; full diet by 48 hours
• Port-site wound check; drain (if placed) removed when output <50 ml/24 hours
• Discharge criteria: tolerating oral fluids, pain controlled on oral analgesia, no fever, satisfactory urine output
PHASE 5 — POST-DISCHARGE RECOVERY IN DESTINATION (DAYS 5–14)
• GAF Healthcare arranges serviced apartment near the hospital for the patient and one attendant
• Wound review at Day 7 post-op; suture removal (if non-absorbable)
• Surgeon review at Day 10–14 to confirm recovery milestones and clear patient for travel
• Restrictions during this phase: no heavy lifting (>5 kg), no driving, no sexual intercourse, no immersion bathing; light walking encouraged daily to reduce DVT risk
• FIT-TO-FLY MILESTONE: Laparoscopic cases cleared for long-haul flight at 10–14 days post-op; open/complex cases at 3–4 weeks post-op (requires surgeon's written fitness-to-fly certificate)
PHASE 6 — LONG-TERM RECOVERY AT HOME (WEEKS 2–8)
• Return to desk work: 2–3 weeks (laparoscopic); 4–6 weeks (open)
• Return to moderate physical activity: 4–6 weeks
• Pelvic physiotherapy referral recommended at 4–6 weeks for chronic pain rehabilitation
• Follow-up fertility assessment (HSG or HyCoSy) at 3 months post-op if infertility was the primary indication
• Follow-up teleconsultation with GAF Healthcare surgeon at 4 and 12 weeks post-operatively included in the package
Risks & Considerations
Pelvic adhesiolysis carries procedure-specific risks that patients must discuss thoroughly with their surgeon during pre-operative consent. The most significant intra-operative risk is inadvertent visceral injury — enterotomy (bowel puncture), cystotomy (bladder injury), or ureteral transection — particularly during dissection of dense adhesions in redo-pelvic surgery; reported rates in high-volume centres are 0.5–2% for laparoscopic cases and up to 4% for open complex cases. Haemorrhage requiring conversion from laparoscopic to open surgery occurs in approximately 1–3% of cases. Post-operative risks include port-site or wound infection (1–3%), urinary tract infection (3–5%), ileus or delayed bowel return (2–5%), and deep vein thrombosis or pulmonary embolism (mitigated by early mobilisation and LMWH prophylaxis). The most clinically important long-term risk is adhesion recurrence: despite the use of anti-adhesion barriers and meticulous surgical technique, studies report adhesion reformation rates of 40–60% by 12 months and up to 85% by 3 years, with symptomatic recurrence requiring re-intervention in 20–30% of patients. Robotic-assisted surgery and the use of intra-peritoneal icodextrin 4% solution are associated with lower recurrence rates compared to conventional laparoscopy without barriers. Patients should also be counselled that adhesiolysis alone does not cure the underlying cause (e.g., endometriosis, recurrent PID) and that adjunct medical therapy — such as GnRH agonists, combined oral contraceptive pills, or progestins — is frequently required post-operatively to suppress disease and reduce recurrence risk. Anaesthetic risks (allergic reaction, aspiration, cardiovascular events) are minimised by thorough pre-operative assessment at all GAF Healthcare partner hospitals.
Top Hospitals for Pelvic Adhesiolysis
The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.
Manipal Hospitals Dwarka
New Delhi, India
Burjeel Hospital for Advanced Surgery Dubai
Dubai, UAE
Kings College Hospital Dubai
Dubai, UAE
Aster Hospital Dubai
Dubai, UAE
Top Doctors for Pelvic Adhesiolysis
Internationally trained specialists in Gynecology. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. Tarang Preet Kaur
MBBS, MS, MRCOG, MCh, Fellowship in Urogynaecology, Fellowship in Cosmetic Gynaecology
Urogynaecologist
Max Super Speciality Hospital, Saket, New Delhi, India
11+ Yearsof experience
Dr. Tarang Preet Kaur is a Consultant in Urogynaecology with over 11 years of clinical experience, currently practicing at Max Super Speciality Hospital, Saket in New Delhi. She holds an MCh in Urogynaecology from Edge Hill University, United Kingdom (2024), the MRCOG from the Royal College of Obstetricians & Gynaecologists, and an MS in Obstetrics & Gynaecology from Maulana Azad Medical College, Delhi. Her dual qualification across India and the UK… Read more
Dr. Amrinder Kaur Bajaj
MBBS, MD — Obstetrics & Gynaecology (Gold Medalist), Senior Residency — Obstetrics & Gynaecology, FRSH — Fellow of the Royal Society of Health, FIAMS — Fellow of the Indian Association of Medical Specialists
Obstetrician & Gynaecologist
Fortis Hospital, Gurgaon, Gurgaon, India
42+ Yearsof experience
Dr. Amrinder Kaur Bajaj is one of Delhi-NCR's most experienced gynaecologists, with over four decades spent caring for women at every stage of life. She currently practises as a Consultant in Obstetrics & Gynaecology at Fortis Hospital, Gurgaon, where she brings together deep clinical knowledge and a quietly reassuring bedside manner that patients — and their families — find genuinely comforting. Her academic journey set a high bar early on. She completed… Read more
Dr. Anuradha Khurana
MBBS, DGO (Diploma in Obstetrics & Gynaecology), PG in High Risk Pregnancy and Infertility
Gynecologist & Obstetrics Specialist
Artemis Hospital, New Delhi, India
20+ Yearsof experience
Dr. Anuradha Khurana is a Senior Consultant in Obstetrics and Gynecology at Artemis Hospital, Delhi, with over two decades of hands-on experience in women's health. She is particularly well regarded for her work in high-risk pregnancy management, uterine conditions like fibroids and endometriosis, and complex gynecological surgeries. Patients and families consistently describe her as someone who takes the time to truly listen — and to explain things in a… Read more
Dr. Aswari Kesari Kapoor
MBBS, DGO (Diploma in Gynaecology & Obstetrics), CPS (College of Physicians and Surgeons), DNB (Diplomate of National Board) — Obstetrics & Gynaecology
Obstetrician & Gynecologist
Indraprastha Apollo Hospital, New Delhi, India
23+ Yearsof experience
Dr. Aswari Kesari Kapoor is a seasoned Obstetrician and Gynecologist with over 23 years of hands-on clinical experience. She practices at Indraprastha Apollo Hospital in New Delhi — one of India's most respected multi-specialty institutions. Over the course of her career, she has built a strong reputation for managing complex gynecological conditions alongside high-risk pregnancies, all with a calm and reassuring bedside manner that patients consistently… Read more
Dr. Bindhu K S
MBBS, DNB (Obstetrics & Gynecology), Fellowship in Minimal Access Surgery, FICOG (Fellowship of the Indian College of Obstetricians and Gynaecologists), Certificate in Gynecologic and Obstetric Sonography, Certificate in Appreciation of Well Being in Fetal Heart Disease
Obstetrician & Gynecologist
Apollo Hospitals, Navi Mumbai, Mumbai, India
23+ Yearsof experience
Dr. Bindhu K S is a seasoned Obstetrician and Gynecologist based in Mumbai, currently practicing at Apollo Hospitals, Navi Mumbai. With over two decades of clinical experience, she brings together expertise in both obstetrics and advanced minimally invasive gynecologic surgery. Whether a patient comes with a complex fibroid, troublesome endometriosis, or a high-risk pregnancy, Dr. Bindhu approaches each situation with careful thought and genuine care. Her… Read more
Frequently Asked Questions — Pelvic Adhesiolysis
In India, laparoscopic pelvic adhesiolysis at a JCI- or NABH-accredited hospital typically costs between USD 1,500 and USD 4,500, depending on surgical complexity, the need for robotic assistance (da Vinci platform), concurrent procedures such as endometriosis excision or salpingolysis, the tier of hospital selected, and the city of treatment (Mumbai, Delhi, Chennai, and Hyderabad are the primary hubs). This cost generally includes the surgeon's fee, anaesthetist's fee, operating theatre charges, 1–3 nights of hospital stay, post-operative medications, and standard nursing care. In the UAE (Dubai or Abu Dhabi), equivalent treatment at a JCI-accredited or DHA-licensed hospital costs between USD 3,500 and USD 9,000, reflecting higher hospital overheads, premium infrastructure, and the cost of living in the UAE. For patients with complex or recurrent adhesive disease requiring robotic surgery and extended hospital stay, costs at the upper end of both ranges apply. India is consistently 40–60% more affordable than the UAE for equivalent surgical expertise and accreditation standards, making it the preferred destination for cost-conscious patients. GAF Healthcare provides a detailed, itemised cost estimate for your specific case before you commit to travel — contact our case management team with your medical records for a personalised quote.
The minimum safe stay before an international flight depends on the surgical approach used. For laparoscopic pelvic adhesiolysis — the most common and minimally invasive technique — most patients are cleared for long-haul air travel at 10–14 days post-operatively, provided they meet all discharge criteria: no fever, satisfactory wound healing, pain controlled on oral analgesics, and normal bowel and bladder function. For robotic-assisted laparoscopic adhesiolysis the recovery timeline is similar. For open (laparotomy) adhesiolysis — reserved for complex or emergency cases — the fit-to-fly period extends to 3–4 weeks post-operatively, as abdominal wall healing must be sufficient to tolerate cabin pressure changes and prolonged immobility. Your operating surgeon will issue a formal fitness-to-fly certificate at the Day 10–14 or Day 21–28 review appointment, which is required by most airlines for post-surgical passengers. GAF Healthcare schedules this review as part of your care package and arranges your accommodation in India or the UAE for the full recovery period, ensuring you do not have to travel prematurely. All patients are advised to wear graduated compression stockings and perform hourly in-seat leg exercises during the return flight to minimise DVT risk.
The success rate of pelvic adhesiolysis depends on the primary indication, surgical technique, adhesion severity (classified by the Peritoneal Adhesion Index/PAI or AFS scoring system), and whether an anti-adhesion barrier is used. For chronic pelvic pain relief, laparoscopic adhesiolysis achieves significant symptomatic improvement in 70–85% of patients at 12 months post-operatively, with robotic-assisted cases at experienced centres reporting outcomes at the higher end of this range. For infertility as the primary indication, clinical pregnancy rates of 30–45% within 12 months of surgery have been reported in patients with tubo-ovarian adhesions as the sole or dominant infertility factor, rising to 50–60% when combined with IVF where tubal damage is irreversible. The most important limitation is adhesion recurrence: despite meticulous surgical technique and the use of anti-adhesion barriers (Seprafilm, Adept/icodextrin 4%), adhesion reformation occurs in 40–60% of patients within 12 months and in up to 85% within 3 years, with symptomatic recurrence requiring re-intervention in approximately 20–30% of cases. Post-operative hormonal suppression (GnRH agonists, progesterone, or combined oral contraceptives) in endometriosis-related cases significantly reduces the risk of symptomatic recurrence. GAF Healthcare partner hospitals are high-volume centres where surgeons perform over 150 pelvic adhesiolysis procedures annually, a factor strongly correlated with better outcomes, lower complication rates, and reduced recurrence in the peer-reviewed literature.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides comprehensive non-medical coordination for every patient travelling for pelvic adhesiolysis, covering the full journey from first enquiry to post-operative discharge.
INDIA — VISA & ENTRY: GAF Healthcare's dedicated visa team assists international patients in obtaining an Indian e-Medical Visa (e-MV), which is available to nationals of over 150 countries, is processed entirely online, and is typically granted within 3–5 business days. The e-MV permits a stay of up to 60 days and allows one accompanying attendant on an e-Medical Attendant Visa (e-MAV). GAF Healthcare prepares and reviews all required documentation — appointment confirmation from the accredited hospital, valid passport scans, passport-size photographs, and the online application — to eliminate delays.
UAE (DUBAI / ABU DHABI) — VISA & ENTRY: Nationals of over 50 countries receive visa-free or visa-on-arrival access to the UAE for 30–90 days. For patients from countries requiring advance visas, GAF Healthcare facilitates a UAE Medical/Tourist Visa through its licensed UAE representative, with processing times of 3–7 business days. Dubai Airports (DXB) and Abu Dhabi International Airport (AUH) both operate 24-hour international arrivals, making the UAE highly accessible from Europe, East Africa, and South Asia.
AIRPORT TRANSFERS: GAF Healthcare arranges private, air-conditioned vehicle transfers from the airport to the hospital on arrival and from the hospital or accommodation to the airport on departure, including wheelchair assistance and porter support for patients with limited mobility post-operatively.
DEDICATED CASE MANAGER & TRANSLATION: Each patient is assigned a named GAF Healthcare case manager who is available via WhatsApp, phone, and email throughout the journey. Certified medical interpreters are available in Arabic, Russian, French, Swahili, Bengali, and other major languages to assist during surgical consultations, consent discussions, and ward rounds.
ATTENDANT ACCOMMODATION: GAF Healthcare partners with serviced apartments, guest houses, and hotels within 5–15 minutes of all partner hospitals, offering attendant accommodation at preferential rates. Packages for a 10–14-day stay are available for one accompanying companion and include daily housekeeping, Wi-Fi, and proximity to pharmacies and outpatient clinics.
POST-DISCHARGE SUPPORT: Follow-up teleconsultation appointments with the operating surgeon are scheduled at 4 weeks and 12 weeks post-operatively and conducted via GAF Healthcare's secure video platform — no return trip required for routine follow-up.